Aims In infective endocarditis, the true incidence of embolic events and metastatic infections remains unknown probably because a large number of events are asymptomatic. The consequences of the prognosis of such events have never been evaluated by a prospective follow-up. This study aimed to assess the incidence of symptomatic or asymptomatic embolic events and metastatic infections in definite infective endocarditis and to determine whether these events carry a risk of mortality.
Introduction
The incidence of embolic events and their consequences, metastatic infections, in infective endocarditis is generally considered to be high. The estimated incidence may be as high as 43% of patients 1 ' 1 , but the true incidence remains unknown 121 . The main reason is probably that a large number of embolic events are asymptomatic (38% for Ting el alP ] ) and could be overlooked in an exclusive clinical study. Very few systematic inquiries have used computed tomography scanning or echocardiography. The prognostic implications of embolic events remain controversial. Some authors have suggested that embolic events may worsen in-hospital mortality 1 ' 41 or overall mortality' 561 , while others found no correlation between cerebral embolic events and mortality' 37 '. Whatever the case, there are very little data on long-term prognosis after such events.
Clinical observations at our institution seemed to show that vascular events complicating infective endocarditis did not increase mortality when their management was correct' 8 ' 10 '. In order to confirm these data in a large series of patients, we set up a study the aim of which was to specify the incidence of embolic events in cases of infective endocarditis and to analyse the long-term prognostic implications of such events.
Patients and methods

Patient selection
For a long time the clinical practice at our institution (Cardiology Unit C of Cardiology Hospital [Pr Ducloux] and Intensive Care Unit of Infectious Diseases Department [Pr Beaucaire] at Lille University Medical Center) was to carefully investigate patients with suspected infective endocarditis in order to detect embolic events or metastatic infections 18 " 101 . Each patient admitted to our tertiary referral centre could thus be considered for our study. However, in order to assess if our practice and its results could have a prognostic significance, a prospective long-term follow-up was required. Thus, only the patients who could have an expected minimal follow-up of 1 year were included.
Between January 1991 and December 1993, 102 patients with suspected or known infective endocarditis were admitted in our two units. Patients exhibiting definite infective endocarditis according to the Duke University criteria were selected'"
1 . Twenty-nine patients who did not meet these criteria were excluded. We also excluded five patients in whom a search for embolic events was not performed because they suffered from congestive heart failure, which excluded medical transport to an X-ray centre or iodine injection.
The 68 remaining patients formed the study population.
Assessment of metastatic infections and/or embolic events
Whatever the clinical presentation, a neurological evaluation with computed tomography scanning or nuclear magnetic resonance imaging and/or an abdominal evaluation with computed tomography scanning or echocardiography were performed in all patients to ascertain symptomatic or asymptomatic metastatic infections. On computed tomography scanning, a neurological ischaemic stroke was said to have occurred if low density lesions were present, a haemorrhagic stroke if high density lesions were present, and a brain abscess if there were oval lesions with a low density centre surrounded by a high density area (appearing after iodine injection). When the chest X-ray was suggestive of multiple pulmonary septic emboli or when the patient had infective endocarditis involving the right-side of the heart, a computed tomography scan, pulmonary angiography or ventilation-perfusion scintigraphy were performed to assess the presence of a pulmonary embolism. Radiological or surgical confirmation was required to diagnose peripheral arterial embolism. If metastatic infection of the musculoskeletal system was suspected (i.e. arthralgia. limitation of motion, joint effusion) gallium citrate radionuclide scanning or nuclear magnetic resonance imaging were performed to assess the diagnosis of infectious arthritis.
Follow-up
Short-term follow-up (during hospital stay and before 45 days had elapsed) was determined from a review of hospital records. Events notified included embolic or metastatic events diagnosed by clinical or radiological examination, valve replacement, need for non-valvular surgery (for example splenectomy) or death.
For long-term follow-up, general practitioners, cardiologists or patients were contacted by telephone and we looked for recurrent infective endocarditis, late valve replacement or death. Whenever possible, control computed tomography scans were performed in patients with metastatic or embolic events.
Indications for open heart surgery
The potential indications for open heart surgery in our patients were: congestive heart failure secondary to valvular dysfunction, myocardial or perivalvular abscess, uncontrolled infection, or prosthetic valve dysfunction due to endocarditis. In the cases with previous embolism or metastatic infections, persistence of large mobile vegetations could also be considered as a potential indication.
Surgery was delayed in cases of cerebral haemorrhage or large or multiple ischaemic cerebral emboli 13121 . Small or moderate ischaemic cerebral lesions were not considered a surgical contraindication. Surgery was also delayed in very severe general conditions, such as renal or hepatic failure, severe brain damage in which consciousness was disturbed, or when there was overwhelming infection.
Patients were not operated on if the infection could be cured with antibiotics, or when valve damage was moderate (no congestive heart failure, no major heart valve regurgitation, no cardiac complication such as myocardial or perivalvular abscess or atrioventricular block).
Statistical analysis
The association between death and embolic events or metastatic infections was analysed using the Chi-square test. Survival was computed by Kaplan-Meier analysis, with the log rank test. Differences were considered significant for P values <005.
Results
Patients
The 68 patients included in the study were aged from 21 to 87 years (mean 52-7 years). There were 50 men and 18 women. Thirty-nine (573%) patients had a predisposition for the development of infective endocarditis: rheumatic heart disease (n = 8), degenerative heart disease (n = 2), mitral valve prolapse (n = 6), congenital heart disease (n = 6: bicuspid aortic valve n = 5, ventricular septal defect n=l), prosthetic valve (n=13: mechanical prosthetic valve n = 6, bioprosthetic valve n = 7) and transvenous cardiac pacemaker (n=4). Blood cultures were positive in 49 cases (72%): Enterococcus n = 8, other Streptococcus species n = 21, Staphylococcus aureus n = 6, coagulase-negative Staphylococcus species n=10, Gram negative bacilli n = 3 and Aspergillus n = 1.
Transthoracic (n = 68) and/or transoesophageal (n = 61) 2-D echocardiograms revealed valvular vegetation in 55 patients (81%). Seven patients (13%) had vegetations on two valves and 48 patients (87%) had vegetations on a single valve. Involved valves were native aortic valves n = 25 (with abscess of the aortic annulus in five patients), native mitral valves n = 22, native tricuspid valves n = 6 and prosthetic valves n = 9. The size of the vegetations was <10 mm in 35 patients (64%) and > or = to 10 mm in 20 patients (36%). The vegetations were sessile in 44 patients (80%) and pedunculated in 11 (20%).
Echocardiograms exhibited findings other than vegetations in seven patients (these findings were associated with vegetations in two patients): ulceration of a prosthetic cusp (n= 1), paravalvular leak (n= 1), valvular perforation (n= 1), ruptured chordae tendineae (n = 2) or isolated ring abscess of the aortic annulus (n = 2).
The major and minor diagnostic criteria used in the diagnosis of these 68 definite episodes of infective endocarditis are given in Table 1 . 
Incidence of metastatic or embolic events
Systemic embolic events or metastatic infections occurred in 35 of the 68 patients (51%) with definite endocarditis. Multiple embolic or metastatic events occurring in 11 patients, 51 events were recorded in 35 patients. Table 2 shows the incidence of all the embolic or metastatic events detected by radiological examination. * Among the 23 patients exhibiting embolic or metastatic abnormalities on neurological examination, eight (35%) were asymptomatic. The main neurological signs observed, in the remaining 15 patients (65%), were focal deficit (n = 9), confusion (n = 2), seizures (n = 2) and 'meningeal' signs with positive culture of the cerebrospinal fluid (n = 2). The only patient with a cerebral haemorrhage ( Table 2) had two computed tomography scan examinations. He was asymptomatic when he had the first computed tomography scan, which was normal; 5 days later, he became symptomatic, a massive cerebral haemorrhage was revealed on the second computed tomography scan, and he died soon afterwards.
Although five out of 13 patients exhibiting abdominal events had numerous lesions, all but one (92%) patient (with pain of the left upper abdominal quadrant due to infarction of the kidney) were asymptomatic. The single case of mesenteric mycotic aneurysm was clinically silent and was incidentally detected on routine abdominal computed tomography scan and characterized on aortic angiography.
A pulmonary infarct or abscess was observed in five patients. Three had infective endocarditis involving the right-side of the heart (tricuspid n = 2, transvenous pacemaker n=l). However, two patients had isolated aortic endocarditis.
Open heart surgery
Early cardiac surgery was performed in 18 of the 68 patients (26%). The distribution of these 18, according to the presence or absence of embolic or metastatic events, is shown in Table 3 . After the patients's admission, surgery was performed after 2 to 43 days. Late cardiac surgery was performed in 15 of the 68 patients (22%). The distribution of these 15, according to the presence or absence of embolic or metastatic events, is shown in Table 3 . Surgery delay ranged from 47 to 298 days. Details regarding early and late surgery are given in Table 4 .
For the 33 patients who underwent operation, surgery delay was not significantly different in those with cerebral embolism compared to those without this condition (see Table 3 ). Among the eight patients who had a contraindication for open heart surgery (see Table 3 ), only three patients had a contraindication due to a neurological cause (critical neurological signs with severe cerebral damage on the computed tomography scan). All three patients died from an acute complication of their infective endocarditis (acute renal failure or septic shock) before their neurological disorder had recovered sufficiently to allow open heart surgery. In the five remaining patients, their surgical contraindications were poor general condition in elderly patients (n = 2), cancer (n=l) or acute renal failure (n=l).
Among the 17 patients with an embolism who were operated on, only one, with a mechanical heart valve, suffered early cerebral post-operative damage (a small ischaemic cerebellar infarct). Another patient, treated with anticoagulants for a mechanical heart valve, had a cerebral haemorrhage 12 months after heart valve replacement.
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Extracardiac surgery
Extracardiac surgery was used to treat embolic complications or metastatic infections in four of the 68 patients (6%): splenectomy (n=l), lower limb arterial embolectomy (n=l), lower limb amputation (n=l), cure of popliteal mycotic aneurysm (n=l). Of these four avoid patients, only one (1/68, 1-5%) was asymptomatic; his embolic complication (splenic abscess) was detected at a routine computed tomography scan (the other three patients had symptoms).
Follow-up and morbidity
All 68 patients included in the study were followed up for 21-2 ±171 months, and only one was lost to follow-up after hospital discharge. Endocarditis recurred in three patients. A control cerebral (n=4), thoracic (n = 2) and/or abdominal computed tomography scan (n = 6) were performed within 6 to 12 months in eight patients with initial embolic or metastatic events. In all cases, the cerebral (n=4), pulmonary (n = 2), renal (n=4), splenic (n = 3) and mesenteric (n=l) abnormalities had disappeared.
Follow-up and mortality
Early death occurred in four of the 33 patients (12%) without metastatic or embolic events and in seven of the 35 patients (20%) with metastatic or embolic events. The difference did not reach statistical significance. According to Kaplan-Meier analysis, the late survival rate was 72% in the group of patients without metastatic or embolic events (curve A, Fig. 1 ) and 68% in the group of patients with metastatic or embolic events (curve B, Fig.   1 ). The difference did not reach statistical significance. The causes of death are reported in Table 5 .
Discussion
Incidence of embolic events and metastatic infections
Our study, based on a reasonably large series of consecutive patients, demonstrates that the incidence of embolic events and metastatic infections (51%) is higher than in previously published clinical studies. In the latter, the incidence of clinically apparent emboli varied considerably from one study to another, ranging from 13% to 43%' 1 -3 -4 -"-13 -15 1. Our incidence is closer to the rate demonstrated in autopsy studies than to the rate in clinical studies. Indeed, in autopsy studies, there is pathological evidence of emboli in 44 to 60% of cases' 16 '.
There are several explanations for our high incidence. First, computed tomography scan examinations or echocardiographies were performed irrespective of the presence or not of clinical signs. Previous studies showed that some of the metastatic infections may have been asymptomatic in as many as 38%' 3 '. A second explanation may be that we selected only patients who had definite endocarditis according to the Duke University criteria'"'. In this latter study, metastatic infections were more frequent in cases of definite endocarditis than in those with possible endocarditis' 11 '. A third explanation may be that a high proportion of our patients had vegetations (81%). Indeed, a link between the presence of vegetations and the occurrence of embolic events has been suggested by some authors' 13171 . However, data are conflicting in this regard; some authors found no increased risk' 1418 '. This high proportion of patients with vegetations in our series is probably because many patients without vegetations were excluded from our study by the use of the Duke University criteria (vegetation is a major criteria). Other hypotheses, which the literature suggests explain the high incidence of embolic events in our series, appear rather invalid. Staphylococcus aureus infective endocarditis was the risk factor for embolism in some reports since an increased rate of emboli were observed among patients with this infection' 5614191 . The proportion of such patients in our series was relatively small, so this risk factor probably has a low impact in our study. The localization of the vegetation is also a risk factor for embolism since an increased risk was observed in cases of mitral vegetation' 1 -4519 '. The number of cases of endocarditis involving the mitral valve was lower than the number of cases of aortic endocarditis, thus this risk factor probably also has a low impact on our results. The size (>10mm) and the mobility of the vegetations are also, for some authors, a risk factor for embolism'
191
. The proportion of large or pedunculated vegetations were relatively low in our series (36% and 20% respectively) and cannot explain our incidence of embolic events.
Prognosis of embolic events and metastatic infections
Neither our study nor its careful patient follow-up demonstrated any significant difference as regards Eur Heart J. Vol. 18, April 1997 prognosis between patients with and without embolic events. Despite a trend towards higher in-hospital mortality in our group of patients with embolic events, statistical significance was not reached and the long-term mortality rates were similar (Fig. 1) '. The prognosis determined by our study could be considered more accurate for several reasons. Our series of patients was derived from our practice which led us, over several years, towards inquiring prospectively about embolic events' 8 "
101
; a long-term follow-up was performed in all patients except one; the series of patients could be considered as homogeneous: all patients had definite endocarditis according to the Duke University criteria, they were consecutive and referred to the same tertiary medical centre, and finally they had a moderately severe illness which permitted investigation.
This similar prognosis in our two groups could be due to the inclusion of patients with asymptomatic embolic events which generally do not carry the same severe prognosis as symptomatic embolism'
31
. Nevertheless, the overall prognosis of our whole series is similar to previous reported studies with prospective follow-up: 30% of the patients died within 1 year after discharge' 201 . Thus, the inclusion of asymptomatic patients cannot really be considered as a bias which could have modified the prognosis of the group of patients with embolic events.
Study limitations
Some patients with a too severe condition were not included in our analysis. These could have introduced a bias in the selection of patients. Thus, our data are specific for patients who can have a computed tomography scan or echocardiography examinations. Conversely, patients without signs of severe illness were probably not referred to our institution which is a tertiary referral centre. Thus, our data cannot be extended to less severe cases.
Not all the study subjects had all the diagnostic tests. This reflects our clinical practice. However, the proportion of patients who had one or more diagnostic tests was rather high (see Table 2 ).
Patients with native valve endocarditis were included as well as those with prosthetic valve endocarditis because previous studies have suggested that the incidence of embolic events is similar in these patients' 7 '.
Study implications
Our study raises the question of the practical usefulness of a systematic inquiry into extra-cardiac embolic events. Neurological evaluation has been previously recommended by other authors' 321 '. The main argument by these authors was that the presence before surgery of a haemorrhagic cerebral infarct (which can be asymptomatic) or of a large ischaemic infarct may lead to an unfavourable outcome after valve replacement' 312 " 2 ' 1 . However, these types of patients are frequently symptomatic, as was the single case of cerebral haemorrhage in our series and all the patients of Ting et alP ] . In such cases, a delay in operation should be sought. A similar recommendation has also been published concerning abdominal evaluation for infarcts or abscesses which are asymptomatic in a large proportion of patients (55% of the patients of Ting et al. with splenic emboli)' 22 '. Such a large proportion of asymptomatic abdominal emboli was confirmed by our study (12 out of 13 [92%] patients). In these cases of abdominal abscess (symptomatic or not), specific extra-cardiac surgery has been recommended in order to avoid post-operative sepsis and recurrent endocarditis involving the newly implanted prosthesis' 22 '.
Our data suggest that the practical implications of detecting embolic or metastatic events (in particular in asymptomatic patients) are rather limited. Despite the presence of extra-cardiac embolic or metastatic events, the prognosis was equivalent in patients with and without embolic events. In other words, the radiological detection of an asymptomatic embolism did not allow a better prognostic evaluation. The second implication concerns the detection of an asymptomatic embolic event which could require specific surgical treatment. In our series, this was very rare since only 1-5% of our patients had an asymptomatic embolic event detected by systematic computed tomography scan which was treated by specific extra-cardiac surgery (other patients with specific extra-cardiac surgery were symptomatic). The third implication concerns the indication or timing of open heart surgery. In our patients, the radiological detection of asymptomatic embolic or metastatic events did not contraindicate or delay open heart surgery (the only three cases with a neurological contraindication were symptomatic). Finally, a normal cerebral computed tomography scan is not an absolute guarantee of a favourable outcome. In our patient in whom death was due to a cerebral haemorrhage, a cerebral computed tomography scan was normal a few days before the occurrence of the cerebral haemorrhage. Thus, further studies are probably required to confirm whether radiological evaluation restricted to patients with symptoms is sufficient. For the moment, the present study confirms that small or moderate cerebral emboli (symptomatic or not) detected by pre-operative computed tomography scan are not a contraindication for cardiac surgery. When infective endocarditis is managed by this way, no significant difference in prognosis is observed between patients with or without embolism.
